John Edward Dickerson, EDD in Belvidere, NJ - Psychologist

John Edward Dickerson, EDD is a Psychologist - Counseling based in Belvidere, New Jersey. John Edward Dickerson is licensed to practice in New Jersey (license number LICENSE #2202) and his current practice location is 40 Castners Rd, Belvidere, New Jersey. He can be reached at his office (for appointments etc.) via phone at (908) 475-8100.

NPI number for John Edward Dickerson is 1376600379 and his current mailing address is 40 Castners Rd, Belvidere, New Jersey. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1376600379.

Contact Information

	John Edward Dickerson, EDD
	40 Castners Rd, Belvidere, NJ 07823-2802
	(908) 475-8100
	(908) 475-8100

Healthcare Provider's Profile

Full Name	John Edward Dickerson
Gender	Male
Speciality	Psychologist - Counseling
Location	40 Castners Rd, Belvidere, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1376600379
Provider Enumeration Date: 01/02/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for John Edward Dickerson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1376600379	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103TC1900X	Psychologist - Counseling	LICENSE #2202 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. John Edward Dickerson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
John Edward Dickerson, EDD 40 Castners Rd, Belvidere, NJ 07823-2802 Ph: (908) 475-8100	John Edward Dickerson, EDD 40 Castners Rd, Belvidere, NJ 07823-2802 Ph: (908) 475-8100

News Archive

People with MCI are impaired in several aspects of executive functioning

By the time older adults are diagnosed with Alzheimer's disease, the brain damage is irreparable. For now, modern medicine is able to slow the progression of the disease but is incapable of reversing it. What if there was a way to detect if someone is on the path to Alzheimer's before substantial and non-reversible brain damage sets in?

Consumers economizing on healthcare in ways that might be dangerous: Poll

More than two-thirds (69%) of Americans currently taking a prescription drug say drug makers have too much influence on doctors' prescribing decisions and half say that doctors are too eager to prescribe a drug when other non-drug options are available for managing a condition. Those are just some of the concerns raised by Americans in a new prescription drug poll by the Consumer Reports National Research Center. More information about the poll is available online at www.consumerreportsenespanol.org.

WHO: 1.1 billion young people at risk of hearing loss due to unsafe use of personal audio devices

Some 1.1 billion teenagers and young adults are at risk of hearing loss due to the unsafe use of personal audio devices, including smartphones, and exposure to damaging levels of sound at noisy entertainment venues such as nightclubs, bars and sporting events, according to WHO. Hearing loss has potentially devastating consequences for physical and mental health, education and employment.

Purdue demonstrates efficacy of Butrans transdermal delivery system for chronic pain in opioid-naive patients

Physicians from Purdue Pharma LP, Stamford, CT, showcased study results that demonstrate the analgesic efficacy and safety of Butrans for the relief of moderate to severe chronic low back pain in opioid-naive patients. Butrans is a transdermal delivery system that provides systemic delivery of buprenorphine, a Schedule III medication, continuously over a 7-day period.

Pfizer aims to implement boosters and a new vaccine based on SARS-CoV-2 Delta variant

The drugmaker Pfizer, one of the companies behind the Pfizer-BioNTech vaccine, or BNT162b2, awaits the green light to develop a COVID-19 booster shot that can protect against emerging variants. Pfizer's COVID-19 vaccine has been shown to be 95% effective in an ongoing large-scale clinical trial against the original SARS-CoV-2 strain.

Psychologist in Belvidere, NJ

Dr. Hanne Unger, PHD
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 309 Second St, Belvidere, NJ 07823
Phone: 908-475-4860

John Edward Dickerson, EDD - Psychologist in Belvidere, NJ